Terms: = Prostate cancer AND ERCC2, TTD, 2068, ENSG00000104884, COFS2, P18074, MGC102762, XPD, MGC126219, MGC126218, EM9 AND Treatment
12 results:
1. Network pharmacology and molecular docking to explore the mechanism of Sheng Xue Bao mixture against iron deficiency anemia.
Wang Y; Qinqin H; Wang H; Zhang H; Zhang X; Liu W; Xiang Z; Gu Y
Medicine (Baltimore); 2023 Sep; 102(37):e35012. PubMed ID: 37713882
[TBL] [Abstract] [Full Text] [Related]
2. Network Pharmacology and Molecular Docking Analysis on Molecular Targets and Mechanisms of Bushen Hugu Decoction in the treatment of Malignant Tumor Bone Metastases.
Sang T; Zhang T; Wang J; Zheng Y
Biomed Res Int; 2022; 2022():2055900. PubMed ID: 36440359
[TBL] [Abstract] [Full Text] [Related]
3. Apalutamide plus Androgen Deprivation Therapy for Metastatic Castration-Sensitive prostate cancer: Analysis of Pain and Fatigue in the Phase 3 TITAN Study.
Agarwal N; McQuarrie K; Bjartell A; Chowdhury S; Pereira de Santana Gomes AJ; Chung BH; Özgüroğlu M; Juárez Soto Á; Merseburger AS; Uemura H; Ye D; Given R; Basch E; Miladinovic B; Lopez-Gitlitz A; Chi KN
J Urol; 2021 Oct; 206(4):914-923. PubMed ID: 34039013
[TBL] [Abstract] [Full Text] [Related]
4. Efficacy and Safety of Non-Steroidal Anti-Androgens in Patients with Metastatic prostate cancer: Meta-Analysis of Randomized Controlled Trials.
Rashid M; Ramesh M; Shamshavali K; Dang A; Patel H; Undela K
Rev Recent Clin Trials; 2020; 15(1):34-47. PubMed ID: 31692438
[TBL] [Abstract] [Full Text] [Related]
5. Evolving Role of Genomics in Genitourinary Neoplasms.
Devitt ME; Dreicer R
Acta Med Acad; 2019 Apr; 48(1):68-77. PubMed ID: 31264434
[TBL] [Abstract] [Full Text] [Related]
6. [Hypofractionated radiation therapy for localized prostate cancer (first experience)].
Vorob'eva TG; Bednyj IV; Drobjazgin EA; Polovnikov ES
Urologiia; 2016 Feb; (1):70-74. PubMed ID: 28247707
[TBL] [Abstract] [Full Text] [Related]
7. Social inequalities and cancer: can the European deprivation index predict patients' difficulties in health care access? a pilot study.
Moriceau G; Bourmaud A; Tinquaut F; Oriol M; Jacquin JP; Fournel P; Magné N; Chauvin F
Oncotarget; 2016 Jan; 7(1):1055-65. PubMed ID: 26540571
[TBL] [Abstract] [Full Text] [Related]
8. Single nucleotide polymorphisms in DNA repair genes as risk factors associated to prostate cancer progression.
Henríquez-Hernández LA; Valenciano A; Foro-Arnalot P; Álvarez-Cubero MJ; Cozar JM; Suárez-Novo JF; Castells-Esteve M; Fernández-Gonzalo P; De-Paula-Carranza B; Ferrer M; Guedea F; Sancho-Pardo G; Craven-Bartle J; Ortiz-Gordillo MJ; Cabrera-Roldán P; Herrera-Ramos E; Rodríguez-Gallego C; Rodríguez-Melcón JI; Lara PC
BMC Med Genet; 2014 Dec; 15():143. PubMed ID: 25540025
[TBL] [Abstract] [Full Text] [Related]
9. Association of a XRCC3 polymorphism and rectum mean dose with the risk of acute radio-induced gastrointestinal toxicity in prostate cancer patients.
Fachal L; Gómez-Caamaño A; Peleteiro P; Carballo A; Calvo-Crespo P; Sánchez-García M; Lobato-Busto R; Carracedo A; Vega A
Radiother Oncol; 2012 Dec; 105(3):321-8. PubMed ID: 23075580
[TBL] [Abstract] [Full Text] [Related]
10. [Conformal radiotherapy for prostate cancer].
Tkachev SI; Matveev VB; Trofimova OP; Nazarenko AV; Pylova IV; Priamikova IuI
Vopr Onkol; 2010; 56(2):215-9. PubMed ID: 20552901
[TBL] [Abstract] [Full Text] [Related]
11. Genetic polymorphisms in XRCC1 associated with radiation therapy in prostate cancer.
Gao R; Price DK; Dahut WL; Reed E; Figg WD
Cancer Biol Ther; 2010 Jul; 10(1):13-8. PubMed ID: 20495366
[TBL] [Abstract] [Full Text] [Related]
12. Therapy and prognosis of tumors of the genitourinary tract after kidney transplantation.
Diller R; Gruber A; Wolters H; Senninger N; Spiegel HU
Transplant Proc; 2005 Jun; 37(5):2089-92. PubMed ID: 15964347
[TBL] [Abstract] [Full Text] [Related]
